Here are the 10-Q quarterly reports from Veralto Corporation (VLTO) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow VLTO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VLTO filings page.
Veralto Corporation (VLTO) reported third-quarter 2026 sales of $1.509 billion, up 7.5% from $1.404 billion, and net earnings of $253 million versus $239 million. Core sales growth was 5.1%; management attributed growth to pricing and higher volume, with acquisitions also contributing to reported sales. Operating profit was $298 million versus $326 million, and operating margin was 19.7% versus 23.2%; gross margin was 60.2% versus 60.1%.
For the nine months, sales were $4.405 billion versus $4.107 billion and net earnings were $748 million versus $686 million. Operating cash flow was $845 million versus $766 million. Veralto repurchased approximately 6 million shares for $523 million during the period; $227 million remained under its $750 million repurchase authorization as of October 2, 2026.
After quarter-end, Veralto completed the $465 million acquisition of Cleanwater1, subject to customary post-closing adjustments, using commercial paper and cash on hand; Cleanwater1 will join Water Quality. Its cost optimization program is expected to incur $85 million to $105 million of charges and be substantially completed by the end of 2028.
Veralto Corporation reported stronger results for the three-month period ended July 3, 2026, with sales of $1,474 million, up 7.6% year over year, and net earnings of $241 million, up from $222 million. Gross margin improved to 61.2% driven by pricing, productivity and tariff recoveries. Diluted EPS was $0.98 for the quarter and $2.00 for the first six months on $2,896 million of year‑to‑date sales and $495 million of net earnings.
Water Quality segment sales rose to $908 million in the quarter and $1,782 million year to date, helped by the January acquisition of In‑Situ for $426 million. Product Quality & Innovation delivered $566 million in quarterly sales. Recurring revenue reached $915 million in the quarter and $1,802 million year to date, about 62% of total.
Operating cash flow for the first six months was $522 million. Veralto funded two acquisitions, including GlobalVision for $195 million, issued $725 million of 4.85% senior notes due 2032 and ended with $2,119 million of cash and $3,379 million of debt. The company repurchased $434 million of stock and began a multi‑year 2026 Cost Optimization Program, recording $29 million of restructuring charges toward an expected $85–$105 million total through 2028.
Veralto Corporation reported stronger results for the three months ended April 3, 2026. Sales reached $1.422 billion, up 6.7%, with core sales growing 1.9% and price contributing 1.9 percentage points. Net earnings increased to $254 million, and diluted EPS rose to $1.02 from $0.90.
Water Quality led growth with sales of $874 million, up 10.1% (3.8% core), while Product Quality & Innovation sales were $548 million, up 1.7% but with a 1.0% core decline. Recurring revenue represented about 62% of total sales, supporting margins and cash flow.
Veralto completed the $426 million cash acquisition of In‑Situ in Water Quality and, after quarter‑end, agreed to acquire GlobalVision for CAD $270 million for PQI. It repurchased roughly 3 million shares for about $300 million, leaving $450 million under its authorization. Operating cash flow was $182 million, while heavy acquisition and buyback spending reduced cash to $1.431 billion. The Board also approved a 2026 Restructuring Program expected to generate $85–$105 million of charges through 2028 to simplify operations and optimize costs.
Veralto Corporation (VLTO) reported higher Q3 2025 results. Sales were $1,404 million, up from $1,314 million a year ago. Gross profit was $844 million and operating profit reached $326 million. Net earnings were $239 million with diluted EPS of $0.95, compared to $0.88 last year. The effective tax rate was 21.9%.
Year-to-date, sales totaled $4,107 million and net earnings were $686 million, delivering diluted EPS of $2.74. Operating cash flow for the nine-month period was strong at $766 million, lifting cash and cash equivalents to $1,775 million at period end. Total debt stood at $2,672 million, including $700 million current.
By segment in Q3, Water Quality generated $856 million of sales and $222 million of operating profit; Product Quality & Innovation delivered $548 million of sales and $133 million of operating profit. Recurring revenue represented approximately 62% of total sales for the nine months ended October 3, 2025. Shares outstanding were 248,297,345 as of October 22, 2025.
Veralto Corporation (VLTO) Q2 FY25 – Form 10-Q snapshot
- Revenue: $1.37 bn, +6.4% YoY; core growth 4.8%. Water Quality (WQ) +6.2% to $825 m; Product Quality & Innovation (PQI) +6.8% to $546 m.
- Profitability: Gross margin 60.0% (-10 bp YoY). Operating profit rose 4.7% to $313 m; WQ margin expanded to 25.6% while PQI margin softened slightly.
- Net earnings: $222 m vs $203 m; diluted EPS $0.89 (+9.9%). Effective tax rate fell to 22.1% from 24.8%.
- Cash flow & liquidity (six-month YTD): CFO $496 m (+35%); capex $31 m; ending cash $1.56 bn vs $1.10 bn at FY-24. Long-term debt $2.67 bn; net cash ≈ $(1.11) bn.
- Balance sheet strength: Equity up 30% YTD to $2.66 bn, aided by earnings and FX translation gains; AOCI loss narrowed to $(892) m.
- Mix & pricing: Recurring revenue ~61% YTD; price contributed ~1.7 pp to Q2 sales growth.
- Geography: Developed markets +7.0% (North America +6.3%, W. Europe +9.2%); High-growth markets +5.0%.
- Guidance & outlook: Management expects sustained demand in municipal/industrial water and steady CPG demand; monitoring macro, FX and tariff risks.